PI11235 Ammonium bromide (CAS No.: 12124-97-9)

Ammonium bromide (CAS No.: 12124-97-9) Description

Ammonium bromide is an inorganic compound with the formula H4BrN. Engineered as a powder, it facilitates controlled reactivity in pharmaceutical synthesis by providing a consistent intermediate state. Its well-defined composition supports predictable kinetic behaviours in chemical reactions. Produced under stringent purification processes, the material integrates into established synthesis pathways, enhancing reproducibility and process optimisation.

Ammonium bromide (CAS No.: 12124-97-9) Applications

1.        Pharmaceutical Synthesis
   - Used as an intermediate in medicinal compound synthesis to achieve pure end products by leveraging controlled reactivity.
   - Applied in reaction pathways to minimise by-product formation by utilising its refined crystallisation properties.

2.        Industrial Chemical Processing
   - Serves as an additive in formulation development to standardise reaction kinetics through consistent composition.
   - Utilised in catalyst research to secure reproducible reaction profiles owing to its minimal impurity levels.

Ammonium bromide (CAS No.: 12124-97-9) Packing

Ammonium bromide powder is securely packaged in moisture-proof, sealed containers to ensure product integrity during storage and transit. The primary container is reinforced with an additional protective layer to mitigate physical impact and contamination. Storage instructions specify a cool, dry environment to maintain optimal chemical stability. Custom packaging options, including desiccant integration and tamper-evident seals, are available upon request.

Additional Information

Pharmaceutical intermediates such as ammonium bromide play a critical role in the synthesis of active pharmaceutical ingredients. Their chemical purity and consistency are paramount for ensuring predictable reaction outcomes and minimising by-product formation. Strict quality control measures, including chromatographic analysis and thermal testing, underpin the reliability of these compounds in research and industrial settings.

Understanding the properties of chemical intermediates aids in optimising synthesis parameters and scaling up production. Materials science principles applied during production—such as controlled crystallisation and impurity reduction—contribute to enhanced process efficiency and product performance, which are essential for advancing pharmaceutical manufacturing methodologies.